Hrvoje Vražić
-
- Diabetes Treatment and Management 11
-
- Cardiac pacing and defibrillation studies 4
- Cardiac electrophysiology and arrhythmias 3
-
- Metabolism, Diabetes, and Cancer 7
-
- Pharmacology and Obesity Treatment 3
-
- School Health and Nursing Education 2
-
- Cardiac Imaging and Diagnostics 2
-
- Nutritional Studies and Diet 2
Hrvoje Vražić
30 papers receiving 317 citations
Peers
Comparison fields: 5 of 62
- Endocrinology, Diabetes and Metabolism 179
- Cardiology and Cardiovascular Medicine 77
- Molecular Biology 128
- Pharmacology 31
- Speech and Hearing 10
Countries citing papers authored by Hrvoje Vražić
This map shows the geographic impact of Hrvoje Vražić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hrvoje Vražić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hrvoje Vražić more than expected).
Fields of papers citing papers by Hrvoje Vražić
This network shows the impact of papers produced by Hrvoje Vražić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hrvoje Vražić. The network helps show where Hrvoje Vražić may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hrvoje Vražić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 7 | |
| 3 | 2019 | 10 | |
| 4 | Abstract 14806: The Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide Improve Cardiovascular and Renal Outcomes Across Most Body Mass Index Categories in Type 2 Diabetes: Results of the LEADER and SUSTAIN 6 Trials | 2018 | 3 |
| 5 | 2018 | 40 | |
| 6 | 2018 | 16 | |
| 7 | 2018 | 8 | |
| 8 | 2017 | 13 | |
| 9 | 2017 | 8 | |
| 10 | 2015 | 23 | |
| 11 | 2014 | 2 | |
| 12 | 2012 | 1 | |
| 13 | 2012 | 1 | |
| 14 | 2012 | 1 | |
| 15 | Metabolic syndrome and cardiovascular diseases | 2011 | 3 |
| 16 | 2011 | 21 | |
| 17 | Oblici i patofiziologija akutnog koronarnog sindroma | 2009 | 1 |
| 18 | 2008 | 13 | |
| 19 | 2008 | 16 | |
| 20 | 2008 | 4 |
About Hrvoje Vražić
Hrvoje Vražić is a scholar working on Endocrinology, Diabetes and Metabolism, Medical Laboratory Technology and Cardiology and Cardiovascular Medicine, having authored 31 papers that have together received 323 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (11 papers), Metabolism, Diabetes, and Cancer (7 papers), Cardiac pacing and defibrillation studies (4 papers), Pharmacology and Obesity Treatment (3 papers), Cardiac electrophysiology and arrhythmias (3 papers), School Health and Nursing Education (2 papers), Cardiac Imaging and Diagnostics (2 papers) and Nutritional Studies and Diet (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (179 citations), Cardiology and Cardiovascular Medicine (77 citations) and Molecular Biology (128 citations). Hrvoje Vražić has collaborated with scholars based in Croatia, Denmark and United Kingdom. Frequent co-authors include Lars Wilkinson, Neil Webb, Subodh Verma, John B. Buse, Mijo Bergovec, Søren Rasmussen, Lawrence A. Leiter, Stephen C. Bain, Richard E. Pratley and Deepak L. Bhatt. Their work appears in journals such as Circulation, Annals of Internal Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.